Greenwich LifeSciences, Inc. (GLSI)
NCM · Common · CUSIP 396879108
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for GLSI and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
396879108
Market Cap
Micro Cap
IPO
9/29/2020 · $5.75/share
Business: Greenwich LifeSciences is a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery.

Company Contact

CEO
Snehal S. Patel
CFO
Snehal Patel
Headquarters
3992 Bluebonnet Dr., Building 14, Stafford, TX 77477
Phone
832-819-3232
Investor Relations
Snehal Patel · 832-819-3232 · info@greenwichlifesciences.com
SEC EDGAR Filings
View filings »